While TMNP show compelling efficacy in acute inflammation, key questions require resolution: First, whether CD4+CD8a+ T cell expansion predispose to post-VILI fibrosis merits investigation using lineage-tracing models. This evidence concerns the gene CD4 and fibrosis.